A Single-arm, Open-lable, Multicenter, Phase II Clinical Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer
Latest Information Update: 07 Feb 2023
At a glance
- Drugs Carboplatin (Primary) ; Etoposide (Primary) ; LP 002-Lepu Biopharma (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Sponsors Taizhou HoudeAoke Biomedical
- 10 Feb 2021 New trial record